{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T11:11:44Z","timestamp":1786273904989,"version":"build-2736575974"},"reference-count":53,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"National Institute on Health","award":["N01DA-13-8908"],"award-info":[{"award-number":["N01DA-13-8908"]}]},{"name":"National Institute on Health","award":["T32AG20494"],"award-info":[{"award-number":["T32AG20494"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Substituted piperazines comprise a substantial proportion of the novel psychoactive substance market. Among the most widely abused piperazine compounds are meta-chlorophenylpiperazine (mCPP), tri-fluoromethylphenylpiperazine (TFMPP), and, especially, benzylpiperazine (BZP), which are commonly incorporated, either alone or in combination, in illicit \u201cparty pills\u201d or \u201cecstasy\u201d formulations. Illicit synthesis of BZP often results in production of an impure by-product dibenzylpiperazine (DBZP), which frequently appears alongside BZP in these formulations; however, despite its ubiquity, little information exists regarding the abuse liability of DBZP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The current study aimed to evaluate the abuse-related behavioral pharmacology of DBZP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>DBZP, mCPP, and TFMPP were tested in parallel in mice in locomotor activity and conditioned place preference assays, and in a drug discrimination assay with rats trained to discriminate either methamphetamine, cocaine, (\u00b1)-3,4-methylenedioxymethamphetamine (MDMA), or -2,5-dimethoxy-4-methylamphetamine(DOM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Each of the compounds tested produced dose-dependent decreases in locomotor activity. DBZP substituted fully for methamphetamine, produced subthreshold drug-appropriate responding for cocaine and MDMA, and failed to substitute for DOM. Conversely, TFMPP and mCPP only produced subthreshold drug-appropriate responding for methamphetamine and MDMA, respectively, and both compounds failed to substitute for cocaine or DOM. None of the compounds tested produced a place preference. DBZP produced convulsions in rats at the highest dose tested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These data indicate that DBZP is more similar to BZP, albeit with lower potency and efficacy, than its serotonergic piperazine counterparts, and is a behaviorally-active compound with some abuse liability and potential for adverse health effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0269881118780613","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T04:51:45Z","timestamp":1529297505000},"page":"802-810","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis"],"prefix":"10.1177","volume":"32","author":[{"given":"Sean B","family":"Dolan","sequence":"first","affiliation":[{"name":"Pharmacology and Neuroscience, University of North Texas Health Science Center at Fort Worth, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-6423","authenticated-orcid":false,"given":"Ritu A","family":"Shetty","sequence":"additional","affiliation":[{"name":"Pharmacology and Neuroscience, University of North Texas Health Science Center at Fort Worth, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Forster","sequence":"additional","affiliation":[{"name":"Pharmacology and Neuroscience, University of North Texas Health Science Center at Fort Worth, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3474-211X","authenticated-orcid":false,"given":"Michael B","family":"Gatch","sequence":"additional","affiliation":[{"name":"Pharmacology and Neuroscience, University of North Texas Health Science Center at Fort Worth, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"bibr1-0269881118780613","first-page":"55","volume":"122","author":"Antia U","year":"2009","journal-title":"N Z Med J"},{"key":"bibr2-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000569"},{"key":"bibr3-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1316.024"},{"key":"bibr4-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300585"},{"key":"bibr5-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1520\/JFS2004239"},{"key":"bibr6-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109102541"},{"key":"bibr7-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e3282f18d8f"},{"key":"bibr8-0269881118780613","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0022-3565(25)10686-1","volume":"274","author":"Callahan PM","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr9-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1021\/jm901189z"},{"key":"bibr10-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1159\/000457905"},{"key":"bibr11-0269881118780613","first-page":"27","volume":"12","author":"Cunningham KA","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"bibr12-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/34.8.464"},{"key":"bibr13-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.07.041"},{"key":"bibr14-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.11.006"},{"key":"bibr15-0269881118780613","first-page":"12794","volume":"69","author":"Drug Enforcement Administration","year":"2004","journal-title":"Federal Register"},{"issue":"46","key":"bibr16-0269881118780613","volume":"42","author":"Drug Enforcement Administration","year":"2009","journal-title":"Microgram Bull"},{"key":"bibr17-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.07.014"},{"key":"bibr18-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246164"},{"key":"bibr19-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(02)01034-X"},{"key":"bibr20-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000237"},{"key":"bibr21-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1501-z"},{"key":"bibr22-0269881118780613","doi-asserted-by":"crossref","unstructured":"Gatch MB, Rutledge M, Forster MJ (2015) Discriminative and locomotor effects of five synthetic cathinones in rats and mice\n                      Psychopharmacology\n                      232: 1197\u20131205.","DOI":"10.1007\/s00213-014-3755-3"},{"key":"bibr23-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e328364166d"},{"key":"bibr24-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(86)90003-7"},{"key":"bibr25-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90464-8"},{"key":"bibr26-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2008.12.003"},{"key":"bibr27-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000667"},{"key":"bibr28-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1007\/BF02431539"},{"key":"bibr29-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb11508.x"},{"key":"bibr30-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.100594"},{"key":"bibr31-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1002\/dta.285"},{"key":"bibr32-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-2081-7"},{"key":"bibr33-0269881118780613","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-3565(25)23232-3","volume":"249","author":"Lucki I","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr34-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_243.x"},{"key":"bibr35-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.03.041"},{"key":"bibr36-0269881118780613","volume-title":"Guide for the Care and Use of Laboratory Animals","volume":"8","author":"National Research Council","year":"2011"},{"key":"bibr37-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.143701"},{"key":"bibr38-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.107383"},{"key":"bibr39-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(84)90424-6"},{"key":"bibr40-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.12573"},{"key":"bibr41-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199304000-00002"},{"key":"bibr42-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-013-1057-x"},{"key":"bibr43-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(88)90390-5"},{"key":"bibr44-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(88)90310-3"},{"key":"bibr45-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(96)00668-6"},{"key":"bibr46-0269881118780613","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.572076"},{"key":"bibr47-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-016-4482-8"},{"key":"bibr48-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.01.024"},{"key":"bibr49-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.6832"},{"key":"bibr50-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00172-8"},{"key":"bibr51-0269881118780613","volume-title":"The Challenge of New Psychoactive Substances: A Report from the Global SMART Programme","author":"United Nations Office on Drugs and Crime","year":"2013"},{"key":"bibr52-0269881118780613","volume-title":"Global Synthetic Drugs Assessment: Amphetamine-type Stimulants and New Psychoactive Substances","author":"United Nations Office on Drugs and Crime","year":"2014"},{"key":"bibr53-0269881118780613","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2007.06.007"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881118780613","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0269881118780613","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881118780613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:07:46Z","timestamp":1777507666000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881118780613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1177\/0269881118780613"],"URL":"https:\/\/doi.org\/10.1177\/0269881118780613","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,18]]}}}